scispace - formally typeset
M

Michael L. Shelanski

Researcher at Columbia University

Publications -  116
Citations -  18451

Michael L. Shelanski is an academic researcher from Columbia University. The author has contributed to research in topics: Apoptosis & Nerve growth factor. The author has an hindex of 61, co-authored 116 publications receiving 17333 citations. Previous affiliations of Michael L. Shelanski include Hunter College & Columbia University Medical Center.

Papers
More filters
Journal ArticleDOI

Microtubule Assembly in the Absence of Added Nucleotides

TL;DR: Tubulin can be purified from guinea pig brain readily and in good yield by two cycles of assembly in glycerol-containing solutions, and is more stable than tubules formed in the absence of these compounds.
Journal ArticleDOI

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Adam C. Naj, +156 more
- 01 May 2011 - 
TL;DR: The Alzheimer Disease Genetics Consortium performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1), two replication stages (stages 2 and 3), and both joint analysis and meta-analysis approaches were used.
Journal ArticleDOI

Primary age-related tauopathy (PART): a common pathology associated with human aging

John F. Crary, +43 more
TL;DR: A new term is recommended, “primary age-related tauopathy” (PART), to describe a pathology that is commonly observed in the brains of aged individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time.
Journal ArticleDOI

Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial.

TL;DR: In an ambulatory care situation in which patients were randomly assigned to either nurse practitioners or physicians, and where nurse practitioners had the same authority, responsibilities, productivity and administrative requirements, and patient population as primary care physicians, patients' outcomes were comparable.
Journal ArticleDOI

Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease

TL;DR: The data imply that the biological effects of head injury may increase the risk of AD, but only through a synergistic relationship with apolipoprotein-epsilon4.